Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma

Anticancer Research

Volumn 22, Issue 6 C, 2002, Pages 4109-4113

  Kao, Ruey Ho ^a   Huang, Li Chi ^a   Hsu, Yung Hisang ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

CpG island; E cadherin; Methylation; Nasopharyngeal carcinoma

Indexed keywords

BISULFITE; DINUCLEOTIDE; GENOMIC DNA; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA EXTRACTION; DNA MODIFICATION; DNA SEQUENCE; DNA TRANSCRIPTION; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; NASOPHARYNX CARCINOMA; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CADHERINS; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; SULFITES;

EID: 0036875226     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Turker MS and Bestor TH: Formation of methylation patterns in the mammalian genome. Mutat Res 386: 119-130, 1997.
2. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 321: 209-213, 1986.
3. Holliday R: DNA methylation and epigenetic inheritance. Philos Trans R Soc Lond B Biol Sci 326: 329-338, 1997.
4. el-Deiry WS, Nelkin BD, Celano P et al: High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 88: 3470-3474, 1991.
5. Issa JP, Vertino PM, Wu J, Sazawal S et al: Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85: 1235-1240, 1993.
6. Belinsky SA, Nikula KJ, Baylin SB et al: Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci USA 93: 4045-4050, 1996.
7. Melki J, Warnecke P, Vincent P et al: Increased DNA methyltransferase expression in leukemia. Leukemia 12: 311-316, 1998.
8. Jones PA, Rideout WM, Shen JC et al: Methylation, mutation and cancer. Bioassays 14: 33-36, 1992.
9. Schmutte C, Yang AS, Nguyen TT et al: Mechanisms for the involvement of DNA methylation in colon carcinogenesis. Cancer Res 56: 2375-2381, 1996.
10. Baylin SB, Herman JG, Graff JR et al: Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196, 1998.
11. Herman JG, Graff JR, Myohanen S et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
12. Graff JR, Herman JG, Myohanen S et al: Mapping patterns of CpG island methylation in normal and neoplastic cells implicated both upstream and downstream regions in de novo methylation. J Biol Chem 272: 22322-22339, 1997.
13. Stirzaker C, Milliar DS, Paul CL et al: Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 57: 2229-2237, 1997.
14. Herman JG, Umar A, Polyak K et al: Incidence and functional consequence of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95: 6870-6875, 1998.
15. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 451-455, 1991.
16. Paul R, Ewing CM, Jarrard DF et al: The cadherin cell-cell adhesion pathway in prostate cancer progression. Br J Urol 79: 37-43, 1997.
17. Graff JR, Herman JG, Lapidus RG et al: E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinoma. Cancer Res 55: 195-199, 1995.
18. Kanai Y, Ushijima S, Hui AM et al: The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinoma. Int J Cancer 71: 355-359, 1997.
19. Yoshiura K, Kanal T, Ochiai A et al: Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92: 7416-7419, 1995.
20. Graff JR, Greenberg VE, Herman JG et al: Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res 58: 2063-2066, 1998.
21. Hwang HN: Nasopharyngeal carcinoma in the People's Republic of China: incidence, treatment, and survival rates. Radiology 149: 305-309, 1983.
22. Hsu MM and Tu SM: Nasopharyngeal carcinoma in Taiwan: clinical manifestations and results of therapy. Cancer 52: 362-368, 1983.
23. Zheng Z, Pan J, Wong YC et al: Downregulation and abnormal expression of E-cadherin and β-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol 30: 458-466, 1999.
24. Lou PJ, Chen WP, Sheen TS et al: Expression of E-cadherin/catenin complex in nasopharyngeal carcinoma: correlation with clinicopathological parameters. Oncol Report 6: 1065-1071, 1999.
25. Frommer M, McDonald LE, Milliar DS et al: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residual in individual DNA strands. Proc Natl Acad Sci USA 89: 1827-1831, 1992.
26. Clark SJ, Harrison J, Paul CL et al: High sensitivity mapping of methylated cytosines. Nucleic Acid Res 22: 2990-2997, 1994.
27. Clark SJ, Frommer M: Bisulphite genomic sequencing of methylated cytosines. In: Taylor GR, ed. Laboratory Methods for the Detection of Mutations and Polymorphisms in DNA. New York: CRC Press; 1997: 151.
28. Berx G, Staes K, van Hengel J et al: Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomic 26: 281-289, 1995.
29. Hennig G, Behrens J, Truss M et al: Progression of carcinoma cells is associated with alteration in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11: 475-484, 1995.
30. Melki JR, Paul C, Vincent RD et al: Hypermethylation of E-cadherin in leukemia. Blood 95: 3208-3213, 2000.